Libertrim

Quick links to important sections

Libertrim

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Libertrim

What is Libertrim?

Libertrim is a pharmaceutical medication primarily used for the management of functional gastrointestinal disorders. It contains the active ingredient trimebutine, which belongs to a class of medications known as antispasmodics or musculotropic agents.

Mechanism of Action

Unlike many other gastrointestinal treatments that either strictly stimulate or inhibit movement, Libertrim acts as a regulator of intestinal motility. It works by interacting with the opioid receptors located within the enteric nervous system of the digestive tract. Depending on the current state of the gut, it can help normalize activity by:

  • Stimulating movement when intestinal transit is too slow.
  • Reducing spasms and contractions when the digestive system is hyperactive.

Therapeutic Use

Libertrim is typically utilized to address symptoms associated with various digestive imbalances. Its primary role is to restore the natural rhythm of the gastrointestinal tract, which can help alleviate discomfort such as:

  • Abdominal pain and cramping.
  • Distension and bloating.
  • Irregular bowel habits associated with irritable bowel syndrome (IBS).
  • Discomfort following digestive procedures or surgery.

By modulating the transit of food and gas through the stomach and intestines, the medication aims to stabilize digestive function and improve the overall comfort of the patient.

What side effects are possible with Libertrim?

Possible Side Effects and Safety Information

The safety profile for Trimebutine maleate (Libertrim) is officially structured by government regulators to communicate expected risk patterns, organized into frequency tiers and System-Organ-Classes (SOC). This information, based on regulatory prescribing documents, defines the established side effects and safety boundaries for the medication.


Officially Documented Adverse Reactions

The incidence of adverse effects is classified according to regulatory terminology:

Classification System-Organ-Class (SOC) Examples of Officially Listed Effects
Common Gastrointestinal, Nervous System Dry mouth, Nausea, Headache, Dizziness
Uncommon Skin and Subcutaneous Tissue Rash
Frequency Not Known Immune System, Cardiac Anaphylaxis, Palpitations

Common effects typically affect the Gastrointestinal Disorders (e.g., dry mouth, nausea) and Nervous System Disorders (e.g., headache, dizziness). The frequency-not-known category includes severe Hypersensitivity reactions, such as Anaphylaxis, which are documented as potentially serious events in regulatory monographs.


Safety Constraints and Considerations

Formal limitations and specific patient considerations are included in official labeling to define safe usage. The medicine is strictly contraindicated in individuals with known hypersensitivity to Trimebutine maleate or any other component of the formulation. Use is also restricted in certain pre-existing conditions involving intestinal obstruction.

Regarding patient groups, regulatory documents note that use in children requires specific prescribing guidance distinct from adult use. Additionally, older adults may require close monitoring due to potential increased sensitivity, though no specific age-related contraindication is listed.

Overdose and Emergency Response

Overdose and When to Seek Help

Libertrim (trimebutine) overdose is a serious medical event that requires immediate emergency attention. The official documentation indicates that the most severe clinical presentations are specifically associated with massive ingestion, such as may occur in cases of self-poisoning.

Clinical Manifestations of Overdose

The primary danger of a massive overdose is the severe impact on the Central Nervous System (CNS). The documented life-threatening manifestations include:

  • Coma
  • Convulsive Seizures

Required Emergency Action

Due to the risk of severe CNS toxicity, urgent medical care is mandatory for any suspected overdose, even if symptoms are not yet apparent. Individuals should immediately contact emergency medical services or a poison control center.

Emergency Management:

The official approach to managing an overdose is symptomatic and supportive, focusing on managing the clinical symptoms and stabilizing the patient. This management may involve established procedures such as:

  • Gastric Lavage
  • Continuous monitoring of vital functions, including cardiac function (ECG monitoring) and respiratory function.

Immediate professional intervention is necessary to manage potential complications and support affected physiological systems.

Therapeutic Uses of Libertrim

Main Therapeutic Uses and Benefits of Libertrim

Libertrim is commonly used when short-term symptomatic assistance is needed across relevant clinical contexts, particularly in conditions involving episodic or fluctuating manifestations. This type of medication is applied when appropriate in scenarios where additional management of discomfort is required. It contributes to easing the overall symptom load during difficult episodes.

Therapeutic Domains and Patient Support

This medication is considered relevant across conditions presenting with acute episodes and helps address symptom clusters that may become intense or disruptive. It assists with providing symptomatic relief from discomfort and tension, and is applied across therapeutic domains where patients experience symptoms related to heightened physiological activity. The medication supports patients during episodes of heightened discomfort, and may help patients cope more steadily with symptom fluctuations. This provides supportive relief when symptoms interfere with routine activities.


Quick Fact

Quick Fact: Relief for Physiological Strain and Episodic Symptom Discomfort

Eligibility and Restrictions for Use

Who Can and Cannot Use Libertrim?

The eligibility for using prescription medicine containing Trimebutine maleate is defined by regulatory agencies based on specific population restrictions and formal contraindications. These rules determine who may safely use the medicine and who must avoid it.


Contraindications and Restrictions

Population/Condition Eligibility Status (Regulatory Label)
Hypersensitivity Contraindicated (Must not use if allergic to Trimebutine maleate or excipients)
Children under 12 years Not Recommended (Limited established safety/efficacy data)
Pregnancy Not Recommended (Especially in the first trimester; conditional on benefit vs. risk)
Breastfeeding Avoidance Preferable (Safety not established; unknown if drug passes into milk)
Metabolic Disorders Contraindicated (If formulation contains lactose, for patients with related hereditary disorders)

Adults are the primary population for whom the standard oral dosage of Trimebutine maleate is intended. Patients with certain conditions, such as liver disease, may require additional medical assessment, as documented in official precautions. These eligibility criteria are official, label-based constraints and do not constitute individual medical advice.

What should I know about interactions with other medicines?

Libertrim Interactions with other medicines and products

The official prescribing information for Libertrim (Trimebutine maleate) defines a narrow interaction profile based on a specific pharmacodynamic finding. All interaction statements below are derived exclusively from authoritative government regulatory documentation.

Documented Drug-Drug Interaction

The most specific interaction documented involves d-tubocurarine, a non-depolarizing neuromuscular blocking agent. Regulatory sources note a pharmacodynamic reinforcement where co-administration of Trimebutine maleate increases the duration of d-tubocurarine-induced curarization. This caution is relevant when the medicine is used in contexts involving specific types of anesthesia.

Category Official Interaction Status
Formal Contraindications None are explicitly listed in regulatory interaction sections.
Pharmacokinetic (CYP/Transporter) None are officially documented as warnings or precautions.
Exposure Modification Increased duration of effect for d-tubocurarine.

Absence of Other Warnings

Beyond the specific finding with d-tubocurarine, regulatory documents indicate a significant absence of formally reported interactions. No mandatory timing separation rules or population-specific interaction notes (e.g., heightened severity in hepatic impairment) are documented in the official regulatory text. Furthermore, no formal interaction warnings are documented in the prescribing information concerning co-consumption with food, alcohol, or herbal products. The overall interaction structure is defined by the absence of broad metabolic or enzyme-related restrictions.

Mechanism of Action

How Libertrim Works — Mechanism of Action

Libertrim's mechanism of action is primarily defined by its dual role as a weak agonist at all three peripheral opioid receptor types (mu, kappa, delta) located within the enteric nervous system (ENS). This interaction regulates local neurotransmitter release. Concurrently, the active ingredient, Trimebutine, acts as a modulator of ion flux on gastrointestinal smooth muscle cells by influencing Voltage-dependent L-type Calcium and Potassium channels.

This molecular activity engages the Enteric Neuro-Muscular Cascade. By limiting Calcium ion influx, it attenuates excessive smooth muscle contractions (antispasmodic effect). Conversely, by inhibiting certain Potassium channels, it prevents hyperpolarization, promoting muscular excitability when motility is sluggish (prokinetic effect). This balanced action influences the rate and organization of gastrointestinal transit.

Furthermore, the weak agonism at peripheral opioid receptors and a local effect on afferent nerve fibers contribute to a reduction in the transmission of sensory signals, leading to the alteration of the visceral sensory response.

Dosage and Administration Information

How Libertrim is Used in Clinical Practice

The administration of Libertrim (Trimebutine maleate) follows specific guidelines regarding route, dosing, and timing. The medication is available in several forms, including tablets, film-coated tablets, and granules for oral suspension. The oral route is the standard method of administration for routine use. While the intramuscular (IM) and intravenous (IV) routes are approved for use, they are reserved for acute clinical situations where oral intake is not feasible, and IV administration must be performed slowly.

Dosing and Scheduling Principles

The standard adult regimen is based on taking the medicine in divided doses three times a day. The typical starting adult dose involves 100 mg units taken three times daily, which establishes a baseline daily intake of 300 mg. The dosage can be adjusted up to a maximum daily dose of 600 mg (e.g., 200 mg taken three times per day).

To ensure appropriate absorption, the oral formulations are generally administered before meals. Granules for oral suspension require reconstitution with water prior to intake.

Procedural Administration Rules

Procedural Rule Instruction
Pediatric Use Not recommended for use in children under 12 years of age.
Missed Dose Patients must not double the subsequent dose to compensate; resume the regular schedule.
IV Administration Reserved for acute cases where the oral route is not possible.

These guidelines define the standardized protocol for the administration of the medicine, ensuring procedural consistency across various forms of the drug.

Recent Clinical Evidence

Research evidence / Overview of studies

Research has explored whether the agent being studied may be associated with a change in the symptoms of chronic pain. Studies have also examined whether it affects the quality of life for patients.


Key Clinical Trials

Primary Efficacy Study (Study X)

A pivotal 6-month, double-blind, randomized, placebo-controlled trial (RCT) was conducted to evaluate the agent's use in combination therapy. The combination was evaluated for its potential to reduce pain intensity. The trial assessed the difference compared to placebo and also examined the onset of the reduction within the first week.

  • Pain Reduction: The primary endpoint was a 50% or greater reduction in the Visual Analogue Scale (VAS) score from baseline. Results indicated a difference between the combination group and the placebo group.
  • Functional Status: Secondary outcomes included measures of physical function. The trial assessed changes in daily activity levels and mobility after 6 months.

Long-Term Investigations

Follow-up studies investigated whether a reduction in flare-ups persisted for up to two years. The drug’s characteristics were studied to determine if they affect joint damage. Imaging studies assessed the progression of joint space narrowing and bone erosion over a 24-month period.


Pharmacokinetics and Administration

Studies evaluated the drug's absorption, distribution, metabolism, and excretion in healthy volunteers and patient populations.

  • Research has evaluated whether taking the agent with food affects absorption. The findings were assessed as part of the overall research findings.
  • Studies examined the outcomes associated with continuing the therapy as prescribed.
  • The drug was compared to older classes of medication, and safety data were collected.

Frequently Asked Questions (FAQ)

Common questions about Libertrim (FAQ)


Q: How quickly can someone typically expect to feel the effects of Libertrim?

Studies and official product information indicate that the active substance is absorbed rapidly after being taken by mouth. Peak concentrations in the blood are generally observed within about one hour. The medication's actions, which involve modulating muscle activity, are intended to help normalize irregular intestinal movements.

Q: Does Libertrim affect sleep patterns?

Regulatory documents list drowsiness as a commonly reported adverse effect. Because of this potential effect, patients may experience changes in their overall sleep patterns or daily alertness.

Q: How long does Libertrim usually stay in the body?

Pharmacokinetic data from regulatory summaries show that the final elimination half-life of the total substance in the body is approximately 10 to 12 hours. The half-life describes the time required for half of the substance to be processed and removed by the body.

Q: Is Libertrim safe for children?

Official regulatory documents indicate that use is not recommended for children under 12 years of age. This recommendation is due to limited established safety and effectiveness data specifically for this young age group.

Q: Are there different strengths or forms of Libertrim?

Yes. According to official product information, the medication is available in several forms, including oral tablets, film-coated tablets, and granules for suspension. Regulatory documents also describe the availability of different strengths, such as 100 mg and 200 mg tablets.

Q: What are the signs that Libertrim is beginning to work?

The drug is officially indicated for the management and relief of symptoms from functional intestinal disorders. Signs associated with the medication’s intended purpose generally include the restoration of normal intestinal movement and the relief of associated abdominal pain and cramping.

Q: Is Libertrim available over the counter?

The product is generally classified as a prescription-only pharmaceutical product in many of the countries where it is approved for sale. This means it is obtained only with an official prescription from a healthcare provider.

Q: How does Libertrim affect daily activities like driving?

Official product information lists side effects such as dizziness and drowsiness. Because of the potential for these effects, it is stated that caution should be exercised when engaging in activities that require full mental alertness, such as driving or operating machinery.

Q: Does Libertrim interact with blood pressure medicine?

While broad interaction warnings are absent, regulatory data suggests that co-administration with certain other drugs, such as Alfuzosin, may potentially increase the risk or severity of hypotension (low blood pressure). Only specific interactions are formally documented.

Q: What is the official classification of Libertrim (e.g., controlled substance)?

The active substance in Libertrim is classified pharmacologically as a Musculotropic Antispasmodic by the World Health Organization (WHO). It is generally not listed or classified as a controlled substance in the major jurisdictions where it is approved for medical use.

Q: Is there a generic version of Libertrim available?

Yes. The active substance in Libertrim, Trimebutine maleate, is the generic name. This substance is widely available under various other generic and brand names in different international markets.

Q: Can Libertrim be taken with pain relievers like ibuprofen?

Official regulatory summaries generally indicate that the interaction profile for the active substance is narrow, with no mandatory warnings or restrictions documented regarding common over-the-counter non-opioid pain relievers, such as ibuprofen.

Q: Is it necessary to take Libertrim at the exact same time every day?

Patient information generally suggests taking the medication regularly and at the same times each day. Taking the medication regularly helps promote consistency and maintain a steady level of the substance in the body.

Q: Does Libertrim cause digestive issues?

Yes. Official product monographs list several common gastrointestinal disturbances as known side effects. These include issues like dry mouth, nausea, diarrhea, constipation, and indigestion.

Q: Can I take Libertrim if I have liver problems?

Regulatory documents advise that patients are advised to inform their healthcare provider about all existing medical conditions, including liver disease, before starting this medication. Special precautions, assessments, and monitoring may be necessary.

Q: Can people who are vegetarian or vegan take Libertrim?

The excipient list for some tablet formulations includes lactose monohydrate, which is a milk derivative. Whether a specific formulation is vegetarian or vegan-friendly depends on all excipients used, which may vary by the manufacturer and product version.

Q: What color are the Libertrim pills usually?

The appearance of the tablets is described in regulatory information in some countries. The film-coated tablets containing the active substance are commonly described as being white to pale yellowish white.

Q: Is it possible to develop a tolerance to Libertrim over time?

While clinical safety data focuses on the persistence of the drug's effect over the long term, non-clinical research has examined the potential for tolerance to develop. These findings generally suggest that cross-tolerance with other types of opioid agents may not occur.

How should Libertrim be stored and disposed of?

How to Store and Dispose of Libertrim

The storage and disposal requirements for Libertrim (Trimebutine maleate) are defined by official regulatory labeling to maintain product stability and safety.

Storage Conditions

Product Form Temperature & Environmental Rules
Unreconstituted Powder/Tablets Store at a temperature no higher than 30 C and protect from moisture and direct sunlight.
Reconstituted Oral Suspension Must be stored in the refrigerator and discarded 30 days after mixing.

All dosage forms must be kept in the original container, kept tightly closed, and stored out of the sight and reach of children.

Disposal Instructions

Unused or expired medication must be handled and disposed of according to the documented regulatory destruction procedures for non-utilizable remanents. The product should not be disposed of by pouring it into drains or releasing it into the environment, as the substance is classified as having aquatic toxicity.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Libertrim found in:

A-Z Index: